Pages that link to "Q35179796"
Jump to navigation
Jump to search
The following pages link to Exome sequencing identifies GRIN2A as frequently mutated in melanoma (Q35179796):
Displaying 50 items.
- The spectrum of SWI/SNF mutations, ubiquitous in human cancers (Q21090801) (← links)
- Human genetics and genomics a decade after the release of the draft sequence of the human genome (Q21245451) (← links)
- Melanoma: from melanocyte to genetic alterations and clinical options (Q21284811) (← links)
- A form of the metabolic syndrome associated with mutations in DYRK1B (Q24297819) (← links)
- NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes (Q24596715) (← links)
- A landscape of driver mutations in melanoma (Q24603357) (← links)
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma (Q24607661) (← links)
- Melanoma genome sequencing reveals frequent PREX2 mutations (Q24610463) (← links)
- A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism (Q24612710) (← links)
- Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes (Q24619351) (← links)
- VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing (Q24628978) (← links)
- Systems Biology Approach for Cancer Vaccine Development and Evaluation (Q26782580) (← links)
- High-throughput sequencing for biology and medicine (Q26823498) (← links)
- New developments in dermatological oncogenetics (Q26853582) (← links)
- Pathways and therapeutic targets in melanoma (Q26865736) (← links)
- Shedding light on melanocyte pathobiology in vivo (Q26866190) (← links)
- Melanoma: from mutations to medicine (Q27024061) (← links)
- Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate (Q27673339) (← links)
- Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6 (Q27680556) (← links)
- The structure and substrate specificity of human Cdk12/Cyclin K (Q27682428) (← links)
- Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution. (Q27690285) (← links)
- BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors (Q27851843) (← links)
- TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma (Q27853068) (← links)
- Signaling, Regulation, and Specificity of the Type II p21-activated Kinases (Q28083745) (← links)
- Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer (Q28251814) (← links)
- Inhibitors of the anaplastic lymphoma kinase (Q28267124) (← links)
- Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing (Q28275103) (← links)
- Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders (Q28279421) (← links)
- Inactivating CUX1 mutations promote tumorigenesis (Q28303563) (← links)
- Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers (Q28383535) (← links)
- Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin (Q28397328) (← links)
- Host modulators of H1N1 cytopathogenicity (Q28481798) (← links)
- Guanine holes are prominent targets for mutation in cancer and inherited disease (Q28533852) (← links)
- Clonal architectures and driver mutations in metastatic melanomas (Q28544919) (← links)
- Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes (Q28546038) (← links)
- Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression (Q28552533) (← links)
- Genome-scale sequencing to identify genes involved in Mendelian disorders (Q28657569) (← links)
- Genetic basis for clinical response to CTLA-4 blockade in melanoma (Q29620594) (← links)
- Impact of the next-generation sequencing data depth on various biological result inferences (Q30587393) (← links)
- A practical method to detect SNVs and indels from whole genome and exome sequencing data (Q30653786) (← links)
- VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data (Q30754874) (← links)
- cnvCapSeq: detecting copy number variation in long-range targeted resequencing data. (Q30852238) (← links)
- Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing (Q30857788) (← links)
- An NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology. (Q31077769) (← links)
- Systematic screening of isogenic cancer cells identifies DUSP6 as context-specific synthetic lethal target in melanoma (Q33618850) (← links)
- Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel (Q33674041) (← links)
- MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line (Q33704699) (← links)
- Integrated analysis of recurrent properties of cancer genes to identify novel drivers (Q33742981) (← links)
- APOBEC3B, a molecular driver of mutagenesis in human cancers (Q33743603) (← links)
- FBXW7 mutations in melanoma and a new therapeutic paradigm (Q33845217) (← links)